Pharmaceutical News

RSS

New GAO report shows price increase for brand-name drugs doubles from 2000 to 2008

A new report from the Government Accountability Office (GAO) that finds “extraordinary price increases” for brand-name drug products from 2000 – 2008 was largely fueled by the “lack of therapeutically equivalent drugs” and “limited competition,” underscores the need for policymakers to promote policies in health reform which increase competition and lower costs, the Pharmaceutical Care Management Association (PCMA) said today.

12 Jan 2010

BioTrends Research Group releases Wave One LaunchTrends: EXTAVIA report

BioTrends Research Group, Inc. announces the release of the Wave One LaunchTrends(®): EXTAVIA report. The survey was completed by U.S. Neurologists Extavia (Interferon beta 1b).

12 Jan 2010

Reducing DA dosage causes acute withdrawal symptoms in Parkinson's patients

New research has shown that reducing the dosage of dopamine agonist (DA) drugs, a mainstay treatment for Parkinson's disease (PD), sometimes causes acute withdrawal symptoms similar to those reported by cocaine addicts -- including anxiety, panic attacks, depression, sweating, nausea, generalized pain, fatigue, dizziness and drug cravings. These symptoms can be severe, and are not alleviated by other PD medications.

12 Jan 2010

Prescribing culture of antipsychotic medications in nursing homes examined

Older adults newly admitted to nursing homes with high rates of antipsychotic prescribing in the previous year are more likely to receive antipsychotic agents, according to a report in the January 11 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. Of these treated patients, some had no identified clinical indication for this therapy.

12 Jan 2010

Department of Health vaccinates 49,078 Pennsylvanians at 33 H1N1 flu clinics

The Department of Health vaccinated 49,078 Pennsylvanians at 33 H1N1 flu clinics held across the state on Jan. 8 and 9. The department urges anyone who has not yet been vaccinated to get immunized.

12 Jan 2010

American Heart Association encourages more Americans to get vaccinated against H1N1

The American Heart Association supports National Influenza Vaccination Week, Jan. 10-16, an effort led by the Department of Health and Human Services and the Centers for Disease Control and Prevention (CDC) to encourage more Americans to get vaccinated against H1N1.

12 Jan 2010

New report on launch trend of Roche's Actemra

BioTrends is pleased to announce the fielding of a new syndicated report, LaunchTrends®: ACTEMRA. Roche, Inc. announced that they received FDA approval for Actemra (generic name: tocilizumab) on January 8th. This represents the first IL-6 receptor inhibitor agent approved for Rheumatoid Arthritis (RA); Actemra is approved for adult patients with moderately-to-severely active RA who have had an inadequate response to one or more TNF antagonist therapies. Actemra represents the fourth IV Infusion product in the RA Market and the first infusion product with monthly maintenance dosing.

12 Jan 2010

Amicus Therapeutics presents corporate outlook for 2010 at Annual J.P. Morgan Healthcare Conference

Amicus Therapeutics today outlined the Company's three key strategic priorities and presented a corporate outlook for 2010 at the 28th Annual J.P. Morgan Healthcare Conference.

12 Jan 2010

Cardene I.V. more effective than intravenous labetalol for BP management in acute stroke patients

EKR Therapeutics, Inc., a specialty pharmaceutical company commercializing acute-care hospital products, today said that interim study data1 demonstrate that Cardene® I.V. (nicardipine hydrochloride) is significantly more effective than intravenous labetalol for the management of blood pressure (BP) in stroke patients.

12 Jan 2010

New findings would allow doctors to tailor drug cocktails for particular viral strains

Chemists at UC San Diego and statisticians at Harvard University have developed a novel way to trace mutations in HIV that lead to drug resistance. Their findings, once expanded to the full range of drugs available to treat the infection, would allow doctors to tailor drug cocktails to the particular strains of the virus found in individual patients.

12 Jan 2010

Atypical antipsychotic use for treating elderly patients with dementia decreases

The use of atypical antipsychotics to treat elderly patients with dementia appears to have decreased following a 2005 Food and Drug Administration (FDA) advisory regarding the risks of these medications in this population, according to a report in the January 11 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

12 Jan 2010

CVS/pharmacy and MinuteClinic urge Americans to protect themselves with H1N1 vaccine

CVS/pharmacy, the nation's leading retail pharmacy and MinuteClinic, the largest retail health care provider in the U.S., is urging more Americans to protect themselves and their families with an H1N1 vaccine during National Influenza Vaccination Week (January 10-16) as designated by U.S. Department of Health and Human Services Secretary Kathleen Sebelius and the Centers for Disease Control and Prevention (CDC).

12 Jan 2010

American Red Cross urges Americans to get vaccinated against H1N1 virus

The H1N1 (swine) flu virus is still prevalent across the nation, and the American Red Cross encourages everyone to get vaccinated against the virus, now that the vaccine is widely available.

12 Jan 2010

Mylan sued in connection with the filing of ANDA with FDA for Armodafinil Tablets

Mylan Inc. (Nasdaq: MYL) today confirmed that it was sued by Cephalon Inc. and Cephalon France in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Armodafinil Tablets, 50 mg, 150 mg and 250 mg.

12 Jan 2010

Isis Pharmaceuticals adds ISIS-APOCIIIRx to its development pipeline to treat TG

Isis Pharmaceuticals, Inc. announced today that it has added a new drug, ISIS-APOCIIIRx, to its development pipeline. ISIS-APOCIIIRx provides a novel approach to treat hypertriglyceridemia, or high levels of triglycerides (TG).

12 Jan 2010

H1N1 flu vaccines and other resources for remaining healthy to be offered at Pennsylvania Farm Show

The Department of Health is offering free H1N1 flu vaccines and other resources for remaining healthy at its exhibit at the Pennsylvania Farm Show, which runs through Jan. 16.

12 Jan 2010

AHF to host protest targeting Merck over the steep price for its key HIV/AIDS drug, Isentress

AIDS Healthcare Foundation (AHF) will host a protest Tuesday, January 12, at 10:30am targeting Merck and Co. Pharmaceuticals over the steep price for its key HIV/AIDS drug, Isentress, during the 28th Annual J.P. Morgan Healthcare Conference in San Francisco.

12 Jan 2010

Experiments show Alzheimer's drug may halt the growth of oesophageal cancer

Cancer of the gullet, or oesophagus, is one of the ten most common cancers in the Western world, and there have been recent alarming increases in the number of cases each year in the US and UK.

12 Jan 2010

ViroPharma signs agreement with Sanquin Blood Supply Foundation to develop and commercialize Cinryze

ViroPharma Incorporated today announced that it has signed an agreement with Sanquin Blood Supply Foundation for rights to develop, file regulatory dossiers, and commercialize Cinryze(TM) (C1 esterase inhibitor [human]) for hereditary angioedema (HAE) as well as for potential new indications in certain European and rest of world (ROW) territories.

12 Jan 2010

GSK exercises option to obtain exclusive license to develop and commercialize Traficet-EN

GlaxoSmithKline (GSK) and ChemoCentryx, Inc. today announced that GSK has exercised its option to obtain an exclusive license for further development and worldwide commercialization of Traficet-EN(TM) (CCX282-B), a specific CCR9 antagonist with the potential to offer a new approach for the treatment of inflammatory bowel diseases, including Crohn's disease.

12 Jan 2010

Pharmaceutical News

New GAO report shows price increase for brand-name drugs doubles from 2000 to 2008

BioTrends Research Group releases Wave One LaunchTrends: EXTAVIA report

Reducing DA dosage causes acute withdrawal symptoms in Parkinson's patients

Prescribing culture of antipsychotic medications in nursing homes examined

Department of Health vaccinates 49,078 Pennsylvanians at 33 H1N1 flu clinics

American Heart Association encourages more Americans to get vaccinated against H1N1

New report on launch trend of Roche's Actemra

Amicus Therapeutics presents corporate outlook for 2010 at Annual J.P. Morgan Healthcare Conference

Cardene I.V. more effective than intravenous labetalol for BP management in acute stroke patients

New findings would allow doctors to tailor drug cocktails for particular viral strains

Atypical antipsychotic use for treating elderly patients with dementia decreases

CVS/pharmacy and MinuteClinic urge Americans to protect themselves with H1N1 vaccine

American Red Cross urges Americans to get vaccinated against H1N1 virus

Mylan sued in connection with the filing of ANDA with FDA for Armodafinil Tablets

Isis Pharmaceuticals adds ISIS-APOCIIIRx to its development pipeline to treat TG

H1N1 flu vaccines and other resources for remaining healthy to be offered at Pennsylvania Farm Show

AHF to host protest targeting Merck over the steep price for its key HIV/AIDS drug, Isentress

Experiments show Alzheimer's drug may halt the growth of oesophageal cancer

ViroPharma signs agreement with Sanquin Blood Supply Foundation to develop and commercialize Cinryze

GSK exercises option to obtain exclusive license to develop and commercialize Traficet-EN

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News